BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25994520)

  • 1. Laryngeal spindle cell carcinoma: A population-based analysis of incidence and survival.
    Dubal PM; Marchiano E; Kam D; Dutta R; Kalyoussef E; Baredes S; Eloy JA
    Laryngoscope; 2015 Dec; 125(12):2709-14. PubMed ID: 25994520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laryngeal Verrucous Carcinoma: A Population-Based Analysis.
    Dubal PM; Svider PF; Kam D; Dutta R; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):799-805. PubMed ID: 26124268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laryngeal Papillary Squamous Cell Carcinoma: A Population-Based Analysis of Incidence and Survival.
    Dutta R; Husain Q; Kam D; Dubal PM; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2015 Jul; 153(1):54-9. PubMed ID: 25917664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laryngeal adenosquamous carcinoma: A population-based perspective.
    Dubal PM; Unsal AA; Echanique KA; Vazquez A; Reder LS; Baredes S; Eloy JA
    Laryngoscope; 2016 Apr; 126(4):858-63. PubMed ID: 26452061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subglottic Squamous Cell Carcinoma: A Population-Based Study of 889 Cases.
    Marchiano E; Patel DM; Patel TD; Patel AA; Xue YE; Eloy JA; Baredes S; Park RC
    Otolaryngol Head Neck Surg; 2016 Feb; 154(2):315-21. PubMed ID: 26607281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Impact of Initial Therapy in Patients with T1-T2 Glottic Squamous Cell Carcinoma.
    Brady JS; Marchiano E; Kam D; Baredes S; Eloy JA; Park RC
    Otolaryngol Head Neck Surg; 2016 Aug; 155(2):257-64. PubMed ID: 27026735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laryngeal Neuroendocrine Carcinoma: A Population-Based Analysis of Incidence and Survival.
    Ghosh R; Dutta R; Dubal PM; Park RC; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2015 Dec; 153(6):966-72. PubMed ID: 26183520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laryngeal chondrosarcoma: a population-based analysis.
    Dubal PM; Svider PF; Kanumuri VV; Patel AA; Baredes S; Eloy JA
    Laryngoscope; 2014 Aug; 124(8):1877-81. PubMed ID: 24474667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinonasal malignancies: A population-based analysis of site-specific incidence and survival.
    Dutta R; Dubal PM; Svider PF; Liu JK; Baredes S; Eloy JA
    Laryngoscope; 2015 Nov; 125(11):2491-7. PubMed ID: 26228792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laryngeal adenoid cystic carcinoma: A population-based perspective.
    Dubal PM; Svider PF; Folbe AJ; Lin HS; Park RC; Baredes S; Eloy JA
    Laryngoscope; 2015 Nov; 125(11):2485-90. PubMed ID: 26153623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.
    Hoffman HT; Porter K; Karnell LH; Cooper JS; Weber RS; Langer CJ; Ang KK; Gay G; Stewart A; Robinson RA
    Laryngoscope; 2006 Sep; 116(9 Pt 2 Suppl 111):1-13. PubMed ID: 16946667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and prognostic indicators in laryngeal lymphoma: A population-based analysis.
    Hong SA; Tajudeen BA; Choi S; Husain IA
    Laryngoscope; 2018 Sep; 128(9):2044-2049. PubMed ID: 29392765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival outcomes in advanced laryngeal cancer.
    Megwalu UC; Sikora AG
    JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):855-60. PubMed ID: 25144163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic trends in management of early-stage laryngeal cancer.
    Mourad M; Dezube A; Moshier E; Shin E
    Laryngoscope; 2016 Apr; 126(4):880-4. PubMed ID: 26526215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
    Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
    Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of radiotherapy on laryngeal cancer survival: a population-based study of 13,808 US patients.
    Zhang H; Travis LB; Chen R; Hyrien O; Milano MT; Newlands SD; Chen Y
    Cancer; 2012 Mar; 118(5):1276-87. PubMed ID: 21773970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years.
    Tamura Y; Tanaka S; Asato R; Hirano S; Yamashita M; Tamaki H; Ito J
    Acta Otolaryngol Suppl; 2007 Feb; (557):62-5. PubMed ID: 17453448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.